
Healthcare / Pharma · NSE
Aakaar Medical Technologies Limited, established in June 2013, is a company focused on aesthetic medical solutions, offering a wide range of specialized cosmetic products and devices. It primarily caters to dermatologists, plastic surgeons, aesthetic physicians, and cosmetologists. The company provides both its own brands—comprising products made in India and devices produced internationally—as well as imported brands from countries like South Korea, Spain, Italy, and Austria. These products are mainly supplied to professionals who either use them during treatments or sell them to end users. Aakaar’s offerings include skincare for home and professional use, injectable and contouring products, hair care solutions such as growth serums and tablets, medifacial kits, and various medical devices. These devices are used for treatments like urinary incontinence, tattoo removal, skin rejuvenation, laser hair reduction, and hair transplants. With a presence across India, the company has a strong network of 90 trained sales and service engineers, supporting a large and satisfied customer base. It distributes its products in multiple states including Delhi, Haryana, Punjab, Chandigarh, Uttarakhand, Uttar Pradesh, Bihar, West Bengal, Assam, Gujarat, Madhya Pradesh, Maharashtra, Karnataka, Telangana, and Tamil Nadu.
Price Band
₹68 – ₹72
Issue Size
₹27.00 Cr
Lot Size
1600 shares
GMP
Est. Listing
₹72
at current GMP
Subscribed
2.25x
overall
Open
20 Jun 2025
Close
24 Jun 2025
Allotment
25 Jun 2025
Refund
26 Jun 2025
Demat Credit
27 Jun 2025
Listing
27 Jun 2025
Designated Registrar: Bigshare Services Private Limited
Allotment Date
25 Jun 2025
Basis finalization
Refunds Initiate
26 Jun 2025
Mandate release
Demat Credit
27 Jun 2025
Shares in demat
Listing Debut
27 Jun 2025
Trading begins
Aakaar Medical Technologies Limited is bringing an initial public offering (IPO) in the Healthcare / Pharma sector with an aggregate issue size of ₹27 Crores. The shares are offered at a price band of ₹68 to ₹72 per equity share on NSE. Currently, investors are tracking the grey market premium (GMP) and institutional subscription multiples closely across BSE and NSE portals.
The public offer consists of a fresh issue and offer-for-sale structured under SEBI regulations. Bidding is open to Qualified Institutional Buyers (QIB), Non-Institutional Bidders (NII/HNI), and Retail Individual Investors (RII). Applications can be submitted online using ASBA or UPI mandate through certified stock brokers and net banking portals.
Following the close of bidding on 2025-06-24, the basis of allotment is scheduled to be finalized on 2025-06-25. Investors can verify their application status online by submitting their PAN card number, Application Number, or DP Client ID on the registrar's official portal (Bigshare Services Private Limited) or the BSE allotment checking window.
Allotment records are updated in batches. If the status is not yet available, please wait a few hours until the basis of allotment is fully finalized.
Since funds are blocked under ASBA/UPI, the bank will automatically release the blocked hold on your funds upon receipt of revocation instructions from the sponsor bank.